Sort
21,453 grants matching “tuberculosis”
Rapid Molecular Detection of Tuberculosis without PCR amplification
$998,383Alfredo Andres Celedon · Scanogen, Inc. · R44 · FY2017 · AI
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
$998,364Sandeep Kasoji · Triangle Biotechnology, Inc. · R44 · FY2023 · AI
Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
$998,235C Robert Horsburgh · Boston University Medical Campus · R01 · FY2017 · AI
Rapid Molecular Detection of Tuberculosis without PCR amplification
$998,008Alfredo Andres Celedon · Scanogen, Inc. · R44 · FY2018 · AI
Supported employment to create a community culture of SARS-CoV-2 rapid testing among people who inject drugs: PeerConnect2Test
$997,902Camille C Cioffi · University Of Oregon · U01 · FY2023 · DA
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$997,875Thomas Joseph Hannan · Fimbrion Therapeutics, Inc. · R44 · FY2023 · AI
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
$997,867Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2024 · AI
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
$997,867Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2023 · AI
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$997,404Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2020 · AI
Improving diagnostic sensitivity for difficult-to-lyse microbial samples with nanodroplet technology
$997,367Sandeep Kasoji · Triangle Biotechnology, Inc. · R44 · FY2024 · AI
Microsensor Arrays for Saliva Diagnostics
$997,289Tufts University Medford · U01 · FY2002 · DE
Collaborative African Genomics Network (CAfGEN)
$996,996Mogomotsi Sandy Matshaba · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2020 · AI
DISSEMINATED TUBERCULOSIS IN HIV INFECTION
$996,915Dartmouth College · R01 · FY2004 · AI
Preclinical development of teixobactin, a new antibiotic
$996,881Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2019 · AI
A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis
$996,814Melissa R Nyendak · Viti, Inc. · R44 · FY2014 · AI
Novel Spectinamide Antibiotics for the Treatment of MDR/XDR Tuberculosis
$996,798Michelle M. Butler · Microbiotix, Inc · R44 · FY2021 · AI
International Clinical Trials Unit
$996,650Duke University · U01 · FY2004 · AI
JHU TRAC: Training and Supporting the Next Generation of TB Researchers
$996,611Petros C Karakousis · Johns Hopkins University · P30 · FY2022 · AI
SBIR Phase II: Stable Prophylactic Antibodies
$996,606Arthur Young · Invvax, Inc. · · FY2025 · TIP
Teixobactin Development for Anthrax
$996,402Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2021 · AI
Teixobactin Development for Tuberculosis
$996,278Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2023 · AI
Lab-on-a-Film Multiplexed Test for Respiratory Mycobacterial Infections
$996,031Christopher Gerard Cooney · Akonni Biosystems, Inc. · R44 · FY2024 · AI
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$994,977Thomas Joseph Hannan · Fimbrion Therapeutics, Inc. · R44 · FY2024 · AI
Bloodstream infection detection directly on whole blood
$994,176Alfredo Andres Celedon · Scanogen, Inc. · R44 · FY2021 · AI
New Animal Models for Tuberculosis
$993,992Michelle Linehan · Johns Hopkins University · N01 · FY2013 · AI